glp 1 agonists in development GLP-1 Receptor Agonist Market Size Science Behind GLP 1 GIP
Description
2023 2 Minute Medicine, Inc
99%+ purity, COA verified
The products are being advertised as more affordable alternatives to blockbuster weight-loss drugs
Certainly, the apparent advantage of tirzepatide, a dual incretin agonist, over GLP-1RA will spark renewed interest in the therapeutic potential of GIP in type 2 diabetes, obesity and related co-morbidities.
To further note, in the field of weight-loss treatment, significant work is underway in parallel, on GIP agonist, amylin agonist, glucagon agonist, PYY agonist, either separately or in combination especially with GLP-1 agonist.
Background: The evidence on berberine stimulating the secretion of GLP-1 in intestinal L cell has been studied
